634
Views
93
CrossRef citations to date
0
Altmetric
Research Article

A Critical Review of the Toxicological Effects of Carrageenan and Processed Eucheuma Seaweed on the Gastrointestinal Tract

&
Pages 413-444 | Published online: 29 Sep 2008

References

  • Abraham, R, Golberg, L, and Coulston, F. Uptake and stor- age of degraded carrageenan in lysosomes of reticu-loendothelial cells of the Rhesus monkey, Macaca Mulatta. Exp Mol Pathol 17:77–93, 1972.
  • Abraham, R, Benitz, KF, Rosenblum, I, Mankes, RF, and Ringwood, N. Studies on Rhesus monkeys (Macaca mulatta) receiving native carrageenan (Chondrus crispus) orally for 7.5 years. Institute of Experimental Pathology and Toxicology. Albany Medical College, submitted to JECFA in 1983.
  • Ahnen, DJ and Byers, T. Proliferation happens. JAMA 280:1095–1096, 1998.
  • Alberts, DS, Martinez, ME, Roe, DJ, Guillén-Rodriguez, JM, Marshall, JR, van Leeuwen, B, Reid, ME, Ritenbaugh, C, Vargas, PA, Bhattacharyya, AB, Ear- nest, DL, Sampliner, RE. Lack of effect of a high- fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med 342:1156–1162, 2000.
  • Anderson, RL. Effect of saccharin ingestion on stool compo- sition in relation to caecal enlargement and increased stool hydration. Fd Chem Toxicol 21: 255–257,1983. Arakawa, S, Okumura, M, Yamada, S, Ito, M, and Tejima, S. Enhancing effect of carrageenan on the induction of rat colonic tumors by 1,2–dimethylhydrazine and its relation to β -glucuronidase activities in feces and other tissues. J Nutr Sci Vitaminol, 32:481–485, 1986.
  • Arakawa, S, Ito, M, and Tejima, S. Promoter function of carrageenan on development of colonic tumors in- duced by 1,2–dimethylhydrazine in rats. J Nutr Sci Vitaminol, 34:577–585, 1988.
  • Arakawa, S, Wakazono, H, Ishihara, H, and Tejima, S. N- acetylneuraminic acid and N-glycolylneuraminic acid in glycopeptides of colonic tumor and mucosa in rats treated with carrageenan and 1,2–dimethylhydrazine. Biochem Biophys Res Comm 159:452–456, 1989.
  • Augenlicht, LH, Richards, C, Corner, G, and Pretlow, TP. Evidence for genomic instability in human colonic aberrant crypt foci. Oncogene 12: 1767–1772,1996. Bach, SP, Renehan, AG, and Potten, CS. Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis 21:469–476, 2000.
  • Benitz, KF, Golberg, L, and Coulston, F. Intestinal effects of carrageenans in the Rhesus monkey. Fd Cosmet Toxicol 11:565–575, 1973.
  • Berenblum, I, and Shubik, P. A new, quantitative approach to the study of the stages of chemical carcinogenesis in the mouse’s skin. Br J Cancer 1:383–391, 1947.
  • Bertram, TA. Gastrointestinal tract. In: Handbook of Toxi- cologic Pathology, WM Haschek, and CG Rousseaux, Eds. Academic Press, San Diego, 1991, 195–249.
  • Bohrman, JS, Burg, JR, Elmore, E, Gulati, DK, Barfkknecht, TR, Niemeier, RW, Dames, BL, Toraason, M, and Langenbach, R. Interlaboratory studies with the Chi- nese hamster V79 cell metabolic cooperation assay to detect tumor-promoting agents. Env Mol Mut 12:33– 51, 1988.
  • Boutwell, RK. Some biological aspects of skin carcinogen- esis. Progr Exp Tumor Res 4:207–250, 1964.
  • Burkitt, DP. Related disease-related cause? Lancet 2:1229– 1231, 1969.
  • Bykorez, AI, and Ivashchenko, YD. Gastrointestinal stem cells and their role in carcinogenesis. In: International Review of Cytology. Vol. 90, pp. 309–370, 1984.
  • Caderni, G, Bianchini, F, Dolara, P, and Kriebel, D. Prolif- erative activity in the colon of the mouse and its modulation by dietary starch, fat, and cellulose. Can- cer Res 49:1655–1659, 1989.
  • Caderni, G, Bianchini, F, Mancina, A, Spagnesi, MT, and Dolara, P. Effect of dietary carbohydrates on the growth of dysplastic crypt foci in the colon of rats treated with 1,2–dimethylhydrazine. Cancer Res 51:3721–3725, 1991.
  • Calvert, RJ and Reicks, M. Alterations in colonic thymidine kinase enzyme activity induced by consumption of various dietary fibers (42778). Proc Soc Exp Biol Med 189:45–51, 1988.
  • Calvert, RJ, and Satchithanandam, S. Effects of graded lev- els of high-molecular-weight carrageenan on colonic mucosal thymidine kinase activity. Nutrition 8:252– 257, 1992.
  • Cohen, BI, Raicht, RF, Deschner, EE, Takahashi, M, Sarwal, AN, and Fizzini, E. Effect of cholic acid feeding on N- methyl-N-nitrosourea-induced colon tumors and cell kinetics in rats. J Natl Cancer Inst 64: 573–576,1980. Cohen, SM. Cell proliferation and carcinogenesis. Drug Metabolism Rev 30:339–357, 1998.
  • Cohen, SM, and Ellwein, LB. Cell proliferation in carcino- genesis. Science 249:1007–1011, 1990.
  • Cohen, SM, and Ellwein, LB. Genetic errors, cell prolifera- tion, and carcinogenesis. Perspectives. Cancer Res 51:6493–6505, 1991.
  • Cohen, SM, Ellwein, LB, Okamura, T, Masui, T, Johansson, SL, Smith, RA, Wehner, JM, Khachab, M, Chappel, CI, Schoenig, GP, Emerson, JL, and Garland, EM. Comparative bladder tumor promoting activity of soduim saccharin, sodium ascorbate and related acids and calcium salts in rats. Cancer Res 51:1766–1777, 1991.
  • Corpet, DE. Personal communication, 1999.
  • Corpet, DE., and Parnaud, G. Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aber- rant crypt foci in rats. Carcinogenesis 20:915–918, 1999.
  • Corpet, DE, Taché, S, and Pfeiffer, G. Carborundum, a bulk similar to dietary fibers but chemically inert, does not decrease colon carcinogenesis. Cancer Lett 114:35– 38, 1997a.
  • Corpet, DE, Taché, S, and Préclaire, M. Carrageenan given as a jelly, does not initiate, but promotes the growth of aberrant crypt foci in the rat colon. Cancer Lett 114:53– 55, 1997b.
  • Coulston, F, Abraham, R, Benitz, K.-F, and Ford, W. Carra- geenans safety evaluation. One year study. Interim Progress Report. Institute of Experimental Pathology and Toxicology. Albany Medical College, 1975a (un- published).
  • Coulston, F, Golberg, MB, Abraham, R, Benitz, K.-F, and Ford, W. Safety evaluation of carrageenans nine months study. Safety evaluation interim progress re- port. Institute of Experimental Pathology and Toxi- cology. Albany Medical College, 1975b (unpublished).
  • Coulston, F, Abraham, L, Benitz, K.-F, and Ford, W. Re- sponse of the livers of male and female rats (Osborne/ Mendel and Sprague-Dawley) to alphacel and a carra- geenan (HMR) for nine months using two different basal diets. Institute of Experimental Pathology and Toxicology. Albany Medical College, 1976 (unpub- lished).
  • Danz, M, and Urban, H. Carcinogens, promotors and suspi- cious drugs; their identical short-term effect in a pro- moting activity test (PAT). Exp Path 17:181–184, 1979.
  • Dietrich, DR. Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit Rev Toxicol 23:77–109, 1993.
  • Di Gregorio, C, Losi, L, Fante, R, Modica, S, Ghidoni, M. Pedroni, M. Tamassia, MG, Gafà, L, Ponz de Leon, M, and Ronucci, L. Histology of aberrant crypt foci in the human colon. Histopathology 30:328–334, 1997.
  • Eldridge, SR, Tilbury, LF, Goldsworthy, TL, and Butterworth, BE. Measurement of chemically induced cell prolif- eration in rodent liver and kidney: a comparison of 5– bromo-2’-deoxyuridine and [3H]thymidine adminis- tered by injection or osmotic pump. Carcinogenesis 12:2245–2251, 1990.
  • Elsenhans, B, Blume, R, and Caspary, WF. Long-term feed- ing of unavailable carbohydrate gelling agents. Influ- ence of dietary concentration and microbiological degradation on adaptive responses in the rat. Am J Clin Nutr 34:1837–1848, 1981.
  • Engster, M, and Abraham, R. Cecal response to different molecular weights and types of carrageenan in the guinea pig. Toxicol Appl Pharmacol 38:265–282, 1976.
  • Fenoglio, CM, and Lane, N. The anatomical precursor of colorectal carcinoma. Cancer 34:819–823, 1974.
  • Fenoglio, CM, Kaye, GI, Pascal, RR, and Lane, N. Defining the precursor lesion of ordinary large bowel carci- noma: implications for cancer prevention. Pathol Ann 12:87–116, 1977.
  • Fenoglio-Preiser, CM. When is a hyperplastic polyp not a hyperplastic polyp? Am J Surg Pathol 23:1001–1003, 1999.
  • Fenoglio-Preiser, CM, and Noffsinger, A. Aberrant crypt foci: A review. Toxicol Pathol 27:632– 642, 1999.
  • Food and Drug Administration (FDA) Bureau of Foods. Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Foods, 1982.
  • Friedell, GH. Carcinoma, carcinoma in situ, and “early le- sions” of the uterine cervix and the urinary bladder: introduction and definitions. Cancer Res 36:2482– 2484, 1976.
  • Friedell, GH, Hertig, AT, and Younge, PA. Carcinoma In Situ of the Uterine Cervix. C Thomas, Springfield, IL, 1960.
  • Fuchs, CS, Giovannucci, EL, Colditz, GA, Hunter, DJ, Stampfer, MJ, Rosner, B, Speizer, FE, and Willett, WC. Dietary fiber and the risk of colorectal cancer and adenoma in women. New Engl J Med 340:169– 176, 1999.
  • Giovannucci, E, Stampfer, MJ, Colditz, G, Rimm, EB, and Willett, WC. Relationship of diet to risk of colorectal adenoma in men. J Natl Cancer Inst 84: 91–98,1992. Glauert, HP, and Bennink, MR. Influence of diet or intrarectal bile acid injections on colon epithelial cell proliferation in rats previously injected with 1,2–dimethylhy- drazine. J Nutr, 113:475–482, 1983.
  • Grice, H.C. (Ed.). The selection of doses in chronic toxicity/ carcinogenicity studies. Current Issues of Toxicology, 9–49, 1984.
  • Hagiwara, A, Miyashia, K, Nakanishi, T, Sano, M, Tamano, S, Asai, I, Nakamura, M, Imaida, K, Ito, N, and Shirai, T. Lack of tumor promoting effects of carrageenan on 1,2–dimethylhydrazine-induced colorectal carcinogen- esis in male F344 rats. J Toxicol Pathol 14:37–43, 2001.
  • Hambly, RJ, Rumney, CJ, Cunningham, M, Fletcher, JME, Rijken, PJ, and Rowland, IR. Influence of diets con- taining high and low risk factors for colon cancer on early stages of carcinogenesis in human flora-associ- ated (HFA) rats. Carcinogenesis 18: 1535–1539,1997. Harris, PJ, and Ferguson, LR. Dietary fibre — its composi- tion and role in protection against colorectal cancer. Mutat Res 290:97–110, 1993.
  • Harris, PJ, and Ferguson, LR. Dietary fibres may protect or enhance carcinogenesis. Mutation Res 443:95–110, 1999.
  • Heinen, CD, Shivapukar, N, Tang, Z, Groden, J, and Alabaster, O. Microsatellite instability in aberrant crypt foci from human colons. Cancer Res 56:5339–5341, 1996.
  • Holden, PR, McGuire, B, Stoler, A, Balmain, A, and Pitts, JD. Changes in gap junctional intercellular communi- cation in mouse skin carcinogenesis. Carcinogenesis 18:15–21, 1997.
  • Holt, P.R., Atillasoy, E.O., Gilman, J., Guss, J., Moss, S.F, Newmark, H, Fan, K, Yang, K, and Lipkin, M. Modu- lation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods. JAMA 280:1074–1079, 1998.
  • Hopkins, J. Carcinogenicity of carrageenan. Fd Cosmet Toxicol 19:779–788, 1981.
  • IARC (International Agency for Research on Cancer) Mono- graph. Carrageenan 31:79–94, 1983.
  • International Food Additives Council and Marinalg International. Carrageenan Monograph. December 1983 (un- published).
  • International Food Additives Council and Marinalg International/CLITAM. Carrageenan Monograph, Septem- ber 1991 (unpublished).
  • International Food Additives Council and Marinalg International/CLITAM. Carrageenan Monograph, 1997 (un- published).
  • Jackson, LI. Salmonella mutation test (Ames test) with a semi-refined carrageenan from two sources. BIBRA Report No. 316/2/1/97 from BIBRA International, Carshalton, Surrey, United Kingdom, 1997 (unpub- lished).
  • JECFA: Joint FAO/WHO Expert Committee on Food Addi- tives. Toxicological evaluation of certain food addi- tives, including anticaking agents, antimicrobials,
  • antioxidants, emulsifiers and thickening agents. World Health Organization Technical Report Series, Seven- teenth Report, 1974, No. 539; FAO Nutrition Meet- ings Report Series, No. 53, 1974.
  • JECFA: Joint FAO/WHO Expert Committee on Food Addi- tives. Toxicological evaluation of certain food addi- tives, including anticaking agents, antimicrobials, antioxidants, emulsifiers and thickening agents. World Health Organization Technical Report Series, Forty- fourth Report, 1999, FAO Nutrition Meetings Report Series, 1999.
  • JECFA: Joint FAO/WHO Expert Committee on Food Addi- tives. Processed eucheuma seaweed (addendum). Safety evaluation of certain food additives. JECFA, 1999.
  • JECFA: Joint FAO/WHO Expert Committee on Food Addi- tives. 57th Meeting. Summary and Conclusions, June, 2001.
  • Kendall, CW, Jandzic, SA, Friday, D, and Rao, AV. Dietary cholesterol enhances preneoplastic aberrant crypt for- mation and alters cell proliferation in the murine co- lon treated with azoxymethane. Nutr Cancer 17:107– 114, 1992.
  • Klaunig, JE and Ruch, RJ. Role of inhibition of intercellular communication in carcinogenesis. Lab Invest 62:135– 146, 1990.
  • Klopman, G, and Rosenkranz, HS. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carci- nogenicity/mutagenicity using MULTI-CASE. Mutat Res 305:33–46, 1994.
  • Klurfeld, DM. Dietary fiber-mediated mechanisms in car- cinogenesis. Cancer Res 52:2055s-2059s, 1992.
  • Kristiansen, E. The role of aberrant crypt foci induced by the two heterocyclic amines 2–amino-3–methyl- imidazo[4,5–f]quinoline (IQ) and 2–amino-1–methyl- 6–phenyl-imidazo[4,5–b]pyridine (PhIP) in the de- velopment of colon cancer in mice. Cancer Lett 110:187–192, 1996.
  • Kristiansen, E, Thorup, I, and Meyer, O. Influence of differ- ent diets on development of DMH-induced aberrant crypt foci and colon tumor incidence in Wistar rats. Nutr Cancer 23:151– 159, 1995.
  • Kristiansen, E, Meyer, O, and Thorup, I. Refined carbohy- drate enhancement of aberrant crypt foci (ACF) in rat colon induced by the food-borne carcinogen 2–amino- 3–methyl-imidazo[4,5–f]quinoline (IQ). Cancer Lett 105:147–151, 1996.
  • Kristiansen, E, Meyer, O, and Thorup, I. The ability of two cooked food mutagens to induce aberrant crypt foci in mice. Europ J Cancer Prev 6:53–57, 1997.
  • Lee, D-YK, Chapkin, RS, and Lupton, JR. Dietary fat and fiber modulate colonic cell proliferation in an interac- tive site-specific manner. Nutr Cancer 20:107–118, 1993.
  • Leegwater, DC, De Groot, AP, and Van Kalmthout-Kuyper, M. The aetiology of caecal enlargement in the rat. Fd Cosmet Toxicol 12:687–697, 1974.
  • Levine, DS, Haggitt, RC. Colon. In: Histology for Patholo- gists, SS Sternberg, Ed. Raven Press, 1992, 573– 591.
  • Litton Bionetics, Inc. Mutagenic evaluation of compound FDS 71–3, sodium carrageenan. PB-245 471. U.S. Department of Commerce, National Technical Infor- mation Service. November, 1972.
  • Litton Bionetics, Inc. Mutagenic evaluation of compound, FDA 71–5977052–14–4 Calcium Carrageenan. Re- port submitted by Litton Bionetics, Inc., to Food and Drug Administration, October 31, 1975.
  • Losi, L, Ronucci, L, Di Gregorio, C, Ponz de Leon, M, and Benhattar, J. K-ras and p53 mutations in human colorectal aberrant crypt foci. J Pathol 178:259–263, 1996.
  • Lubin, F, Rozen, P, Arieli, B, Farbstein, M, Knaani, Y, Bat, L, and Farbstein, H. Nutritional and lifestyle habits and water-fibers interaction in colorectal adenoma etiology. Cancer Epidemiol Biomarkers Prev 6:79– 85, 1997.
  • Magnuson, BA and Bird, RP. Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid. Cancer Lett 68:15–23, 1993.
  • Magnuson, BA, Carr, I, and Bird, RP. Ability of aberrant crypt foci characteristics to predict colonic tumor in- cidence in rats fed cholic acid. Cancer Res 53:4499– 4504, 1993.
  • Mallett, AK, Wise, A, and Rowland, IR. Hydrocolloid food additives and rat cecal microbial enzyme activities. Fd Chem Toxic 22:415–418, 1984.
  • Mallett, AK, Rowland, IR, Bearnc, CA, and Nicklin, S. Influence of dietary carrageenans on microbial biotransformation activities in the cecum of rodents and on gastrointestinal immune status in the rat. Toxicol Appl Pharmacol 78:377–385, 1985.
  • McLellan, EA, and Bird, RP. Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res 48:6187–6192, 1988.
  • McSherry, CK., Cohen, BI, Bokkenheuser, VD, Mosbach, EH, Winter, J, Matoba, N, and Scholes, J. Effects of calcium and bile acid feeding on colon tumors in the rat. Cancer Res 49:6039– 6043, 1989.
  • Michel, C, and Macfarlane, GT. Digestive fates of soluble polysaccharides from marine macroalgae: involvement of the colonic microflora and physiological conse- quences for the host. J Appl Bacterial 80:349–369, 1996.
  • Miller, DR, Istone, L, Werner, B, Young, W, Blight, AR, and Burns, FJ. Failure of the tumor promoter 12–O- tetradecanoylphorbol-13–acetate (TPA) to inhibit cell- cell coupling in newborn mouse epidermal cells and Chinese hamsters V79 cells under non-standard cul- ture conditions. Carcinogenesis 8:847–850, 1987.
  • Miller, JA and Miller, EC. Ultimate chemical carcinogens as reactive mutagenic electrophiles. In: Origins of Hu- man Cancer, HH Hiatt, Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, 1977, 605–627.
  • Mori, H, Ohbayashi, F, Hirono, I, Shimada, T, and Williams, GM. Absence of genotoxicity of the carcinogenic sulfated polysaccharides carrageenan and dextran sul- fate in mammalian DNA repair and bacterial mutage- nicity assays. Nutr Cancer 6:92–97, 1984.
  • Nelson, RL. Dietary minerals and colon carcinogenesis (Re- view). Anticancer Res 7:259–270, 1987.
  • Newberne, PM, Conner, MW, and Estes, P. The influence of food additives and related materials on lower bowel structure and function. Toxicol Pathol 16:184–197, 1988.
  • Nilson, HW., and Wagner, JA. Feeding test with carrag- eenan. Food Res 24:234–239,1959.
  • Norton, IT, and Goodall, DM. Role of cations in the confor- mation of iota and kappa carrageenan. J Chem Soc Faraday Trans I 79:2475–2488, 1983.
  • Nucci, MR, Robinson, CR, Longo, P, Campbell, P, and Hamilton, SR. Phenotypic and genotypic characteris- tics of aberrant crypt foci in human colorectal mu- cosa. Hum Pathol 28:1396–1407, 1997.
  • Organization for Economic Cooperation and Development (OECD). Guidelines for Testing of Chemicals; Chronic Toxicity Studies, 1981.
  • Organization for Economic Cooperation and Development (OECD). Guideline for Testing of Chemicals; Re- peated Dose 90–Day Oral Toxicity Study in Rodents, 1998.
  • Otori, K, Sugiyama, K, Haseve, T, Fukushima, S, and Esumi, H. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant in- crease in cell proliferation. Cancer Res 55:4743–4746, 1995.
  • Owen, DA, and Kelly, JK. Large intestine and anus. In: Anderson’s Pathology, I. Damjanov and J. Linder, Eds. 10th ed., Vol. 2. Mosby-Year Book, Inc., St. Louis, 1996, 1741–1778.
  • Pereira, MA, and Khoury, MD. Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon. Cancer Lett 61:27–33, 1991.
  • Perret, AG, Mosnier, JF, Buono, JP, Berthelot, P, Chipponi, J, Balique, JG, Cuilleret, J, Dechelotte, P, and Boncheron, S. The relationship between MID-1 pro- liferation index and outcome in pancreatic neuroen- docrine tumors. Am J Clin Pathol 109: 286–293,1998. Pitot, HC, and Dragan, YP. Facts and theories concerning the mechanisms of carcinogenesis. FASEB J. 5:2280–2286,1991.
  • Potter, JD. Fiber and colorectal cancer — where to now? N Engl J Med 340:223–224, 1999.
  • Pretlow, TP. Aberrant crypt foci and K-ras mutations: ear- liest recognized players or innocent bystanders in colon carcinogenesis. Gastroenterology 108:600– 603, 1995.
  • Robbins, MC. A 90–day feeding study in the rat with semi- refined carrageenan from two sources, including a recovery phase. Unpublished report of Project No. 3160/1/2/97 from BIBRA International, Charshalton, Surrey, United Kingdom, 1997.
  • Roncucci, LC, Pedroni, M, Fante, R, Di Gregorio, C, and Ponz de Leon, M. Cell kinetic evaluation of human colonic aberrant crypts. Cancer Res 53:3726–3729, 1993.
  • Rowland, IR, and Mallet, AK. Dietary fibre and the gut microflora – their effects on toxicity. Div Toxicol Environ Sci 12:125–138, 1986.
  • Ruch, RJ and Klaunig, JE. Effects of tumor promoters, genotoxic carcinogens and hepatocytotoxins on mouse hepatocyte intercellular communication. Cell Biology Toxicol. 2:469–483, 1986.
  • Ruch, RJ, Klaunig, JE, Kerchaert, GA, and LeBoeuf, AL. Modification of gap junctional intercellular commu- nication by changes in extracellular pH in Syrian ham- ster embryo cells. Carcinogenesis 11:909–913, 1990.
  • Rudolph, P, Knüchel, R, Endl, E, Heidebrecht, H-J, Hofstädter, F, Parwaresch, R. The immunohistochemi- cal marker Ki-S2: cell cycle kinetics and tissue distri- bution of a novel proliferation-specific antigen. Mod Pathol 11:450–456, 1998.
  • Rustia, M, Shubik, P, and Patil, K. Lifespan carcinogenicity tests with native carrageenan in rats and hamsters. Cancer Lett 11:1–10, 1980.
  • Salyers, AA, West, SEH, Vercellotti, JR, and Wilkins, TD. Fermentation of mucins and plant polysaccharides by anaerobic bacteria from the human colon. Appl Environ Microbiol 34:529– 533, 1977.
  • Schatzkin, A, Lanza, E, Corle, D, Lance, P, Iber, F, Caan, B, Shike, M, Weissfeld, J, Burt, R, Cooper, MR, Kikendall, JW, and Cahill, J. Lack of effect of a low- fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med 342:1149–1155, 2000.
  • Shannon, J, White, E, Shattuck, AL, and Potter, JD. Rela- tionship of food groups and water intake to colon cancer risk. Cancer Epidemiol Biomarkers Prev 5:495– 502, 1996.
  • Shivapurkar, N, Tang, ZC, and Alabaster, O. The effect of high-risk and low-risk diets on aberrant crypt and colonic tumor formation in Fischer-344 rats. Carcino- genesis 13:887–890, 1992.
  • Shubik, P. Progression and promotion. J Natl Cancer Inst 73:1005–1011, 1984.
  • Sigdestad, CP, Bauman, J, and Lesher, SW. Diurnal fluctua- tions in the number of cells in mitosis and DNA synthesis in the jejunum of the mouse. Exp Cell Res 58:159–162, 1969.
  • Siu, I.-M, Robinson, DR, Schwartz, S, Kung, H.-J, Pretlow, TG, Petersen, RB, and Pretlow, TP. The identification of monoclonality in human aberrant crypt foci. Can- cer Res 59:63–66, 1999.
  • Slaga, TJ. Mechanisms involved in the two-stage carcino- genesis in mouse skin. In: Mechanisms of Tumor Promotion - Tumor Promotion and Skin Carcinogen- esis, TJ Slaga, Ed. Vol. II, CRC Press, Boca Raton, 1984, 1–16.
  • Stanford Research Institute. Study of mutagenic effects of calcium carrageenan (FDA NO. 71–5). March 1972. Suzuki, J, Hye-Kyung, N, Upham, BL, Chang, C, Trosko, JE. -Carrageenan-induced inhibition of gap-junctional intercellular communication in rat liver epithelial cells. Nut Cancer 36:122–128, 2000.
  • Sylianco, CYL, Balboa, J, Serrame, E, and Guantes, E. Non- genotoxic and antigenotoxic activity of PNG carrag- eenan. Philipp J Sci 122:139–153, 1993.
  • Taché, S, Peiffer, G, Millet, A-S, and Corpet, DE. Carrag- eenan gel and aberrant crypt foci in the colon of conventional and human flora-associated rats. Nutr Cancer 37:75–80, 2000.
  • Takayama, T, Katsuki, S, Takahashi, Y, Ohi, M, Nojiri, S, Sakamaki, S, Kato, J, Kogawa, K, Miyake, H, and Niitsu, Y. Aberrant crypt foci of the colon as precur- sors of adenoma and cancer. N Engl J Med 339:1277– 1284, 1998.
  • Thorup, I. Histomorphological and immunohistochemical characterization of colonic aberrant crypt foci in rats: relationship to growth factor expression. Carcinogen- esis 18:465–472, 1997.
  • Thorup, I, Meyer, O, and Kristiansen, E. Effect of a dietary fiber (beet fiber) on dimethylhydrazine-induced colon cancer in Wistar rats. Nutr Cancer 17: 251–261,1992. Thorup, I, Meyer, O, and Kristiansen, E. Influence of a dietary fiber on development of dimethylhydrazine- induced aberrant crypt foci and colon tumor incidence in Wistar rats. Nutr Cancer 21:177–182, 1994.
  • Thorup, I, Meyer, O, and Kristiansen, E. Effect of potato starch, cornstarch and sucrose on aberrant crypt foci in rats exposed to azoxymethane. Anticancer Res 15:2101–2106, 1995.
  • Tobacman, JK. Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ Health Perspect 109:983–994, 2001.
  • Trock, B, Lanza, E, and Greenwald, P. Dietary fiber, veg- etables, and colon cancer: Critical review and meta- analyses of the epidemiologic evidence. J Natl Can- cer Inst 82:650–661, 1990.
  • Troncale, F, Hertz, R, and Lipkin, M. Nucleic acid metabo- lism in proliferating and differentiating colonic cells of man and in neoplastic lesions of the colon. Cancer Res 31:463–467, 1971.
  • United States Adopted Names (USAN) Council. List No. 297, New Names — Poligeenan. Clin Pharmacol Ther 44: 246–248, 1988.
  • Uno, Y, Omoto, T, Goto, Y, Asai, I, Nakamura, M, Maitani, T. Molecular weight distribution of carrageenans stud- ied by a combined gel permeation/inductively coupled plasma (GPC/ICP) method. Food Add Contam 18:763– 772, 2001.
  • Wargovich, MJ, Jimenez, A, McKee, K, Steele, VE, Velasco, M, Woods, J, Price, R, Gray, K, and Kelloff, GJ. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Car- cinogenesis 21:1149–1155, 2000.
  • Watanabe, K, Reddy, BS, Wong, CQ, and Weisburger, JH. Effect of dietary undegraded carrageenan on colon carcinogenesis in F344 rats treated with azoxymethane or methylnitrosourea. Cancer Res 38:4427–4430, 1978.
  • Weiner, ML. Intestinal transport of some macromolecules in food. Fd Chem Toxicol 26:867–880, 1988.
  • Weiner, ML. Toxicological properties of carrageenan. Agents Actions 32:46–51, 1991.
  • Whiteley, LO. Colonic mucosal aberrant crypt foci: Are they useful intermediate endpoints for predicting and un- derstanding the development of colonic mucosal neo- plasia? Toxicol Pathol 27:643–644, 1999.
  • Wilcox, DK, Higgins, J, and Bertram, TA. Colonic epithelial cell proliferation in a rat model of nongenotoxin- induced colonic neoplasia. Lab Invest 67:405–411, 1992.
  • Winawer, SJ, and Shike, M. Dietary factors in colorectal cancer and their possible effects on earlier stages of hyperproliferation and adenoma formation. J Natl Cancer Inst 84:74–75, 1992.
  • Wright, N, and Alison, M. The Biology of Epithelial Cell Populations. Vol. I-II. Clarendon Press, Oxford, 1984. Yokota T, Sugano, K, Kondo, H, Saito, D, Sugihara, K, Fukuyama, N, Ohkura, H, Ochiai, A, and Yoshida, S. Detection of aberrant crypt foci by magnifying colonoscopy. Gastrointest Endosc 46:61–65, 1997.
  • Zeilmaker, MJ and Yamasaki, H. Inhibition of junctional intercellular communication as a possible short-term test to detect tumor-promoting agents: Results with nine chemicals tested by dye transfer assay in Chinese hamster V79 cells. Cancer Res 46:6180–6186, 1986.
  • Zhang, X-M, Stamp, D, Minkin, S, Medline, A, Corpet, DE, Bruce, WR, and Archer, MC. Promotion of aberrant crypt foci and cancer in rat colon by thermolyzed protein. J Natl Cancer Inst 84:1026–1030, 1992.
  • Zoran, DL, Turner, ND, Taddeo, SS, Chapkin, RS, and Lupton, JR. Wheat bran diet reduces tumor incidence in a rat model of colon cancer independent of effects on distal luminal butyrate concentrations. J Nutr 127:2217–2225, 1997.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.